OutSee Secures £1.8m in Seed Funding to Transform Drug Discovery
Deal News | Jun 24, 2025 | UK Tech Funding
University of Cambridge spinout OutSee, a drug discovery company using an AI-based predictive genomics approach, has raised £1.8m in seed funding. The round was led by Ahren Innovation Capital, with contributions from Kadmos Capital, Empirical Ventures, and Panacea Ventures, to support the company's growth strategy. OutSee's Nomaly technology predicts disease and phenotype directly from a genome, foregoing pattern-matching and instead using predictive modelling to draw insights from molecular and cellular biology. This advancement allows for the analysis of smaller datasets and previously analyzed data, bringing new insights to light. The company has seen over £500,000 in grants from Innovate UK for its technology extensions. Ahren's Dr. Joanna Green and Empirical Ventures' Dr. Jonathan Matlock expressed their support for OutSee's potential to transform the drug discovery field.
Sectors
- Biotechnology
- Artificial Intelligence
- Venture Capital
Geography
- United Kingdom – OutSee is a University of Cambridge spinout and has engaged with UK-based investors and grants.
Industry
- Biotechnology – OutSee operates in the biotechnology sector, developing AI-based genomics technologies for drug discovery.
- Artificial Intelligence – The company's use of AI for predictive genomics establishes its relevance to the AI industry.
- Venture Capital – Involvement of multiple VC firms indicates participation from the venture capital industry.
Financials
- £1.8m – The amount raised by OutSee in its seed funding round.
- £500,000 – Grants received from Innovate UK for technology extensions.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| OutSee | Target Company | Company | A University of Cambridge spinout focusing on AI-based genomics for drug discovery. |
| Ahren Innovation Capital | Lead Investor | Company | The lead investor in OutSee's seed funding round. |
| Kadmos Capital | Investor | Company | Participated in OutSee's seed funding round. |
| Empirical Ventures | Investor | Company | Participated in OutSee's seed funding round. |
| Panacea Ventures | Investor | Company | Participated in OutSee's seed funding round. |
| Innovate UK | Funding Source | Government | Provided over £500,000 in precision medicine grants to OutSee. |
| Dr. Julian Gough | Chief Executive and Founder | Person | Inventor of OutSee's Nomaly technology. |
| Dr. Joanna Green | Representative of Ahren Innovation Capital | Person | Commented on the potential of OutSee's technology. |
| Dr. Jonathan Matlock | Co-founder and General Partner at Empirical Ventures | Person | Expressed support for OutSee's innovative approach. |